Cost estimates of chronic hepatitis B virus for the Brazilian Unified Health System in 2005;Estimativas de custo da hepatite crônica B no Sistema Único de Saúde Brasileiro em 2005

Revista da Associacao Medica Brasileira

Volumn 53, Issue 6, 2007, Pages 486-491

  Castelo, Adauto ^a   Pessôa, Mario G ^a   Barreto, Tânia C B B ^a   Alves, Marcia R D ^a   Araújo, Denizar Vianna ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chronic; Costs and cost analysis; Health care costs; Hepatitis B

Indexed keywords

EID: 38149096996     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0104-42302007000600013     Document Type: Article

References (15)

1. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, et al. Universal hepatitis B vaccination in Taiwan and incidence of hepatocellular carcinoma in children: Taiwan Childhood Hepatoma Study Group. N Engl J Med. 1997:336:1855-9.
2. Silveira TR, Fonseca JC, Rivera L, Fay OH, Tapia R, Santos JI, et al. La seroprevalencia de hepatitis B en América Latina. Rev Panam Salud Publica. 1999;6:378-83.
3. Bensabath G, Hadler SC, Soares MC, Fields H, Dias LB, Popper H, et al. Hepatitis dela virus infection and Labrea hepatitis in the Amazon basin. JAMA. 1987;258:479-83.
4. Focaccia R, Conceição OJG, Junior HS, Sabino E, Bassit L, Nitrini DR, et al. Estimated prevalence of viral hepatitis in the general population of the municipality of São Paulo, measured by a serologic survey of a stratified, randomized and residence-based population. Braz J Infect Dis. 1998;2:269-84.
5. Food and Drug Administration. U.S. Department of Health and Human Services. Rockville; 2005. [cited 2006 jul 17]. Available from: http://www.fda.gov.
6. DATASUS. Ministério da Saúde. Brasília; 2005. [cited 2006 jul 17]. Disponível em: http://www.datasus.gov.br.
7. Li SC, Ong SC, Lim SG, Yeoh KG, Kwong KS, Lee V, et al. A cost comparison of management of chronic hepatitis b and its associated complications in Hong Kong and Singapore. J Clin Gastroenterol. 2004; 38(Suppl 10) S136-43.
8. Yang BM, Kim CH, Kim JY. Cost of chronic hepatitis B infection in South Korea. J Clin Gastroenterol. 2004; 38(Suppl 10):S153-7.
9. Zhigiang G, Zhaohui D, Qinhuan W, Dexian C, Yunyun F, Hongtao L, et al. Cost of chronic hepatitis in China. J Clin Gastroenterol. 2004;38(10Suppl):S175- 8.
10. Brown RE, De Cock ED, Colin X, Antonanzas F, Iloeje UH. Hepatitis B management cost in France, Italy, Spain and the United Kingdom. J Clin Gastroenterol. 2004;38(Suppl 10):S169-74.
11. Lee TA, Veenstra DL, Iloeje UH, Sullivan SD. Costs of chronic hepatitis B infection in the United States. J Clin Gastroenterol. 2004;38(Suppl 10):S144-7.
12. Gagnon YM, Levy AR, Iloeje UH, Briggs AH. Treatment costs in Canada of health conditions resulting from chronic hepatitis B infection. J Clin Gastroenterol. 2004;38(Suppl 10):S179-86.
13. Butler JR, Pianko S, Korda RJ, Nquyen S, Gow PJ, Roberts SK, et al. The direct cost of managing patients with chronic hepatitis B infection in Australia. J Clin Gastroenterol. 2004;38(Suppl 10):S187-92.
14. Chen J C et al. Risk of hepatocellular carcinoma across biological gradient of serum hepatits B virus DNA level. JAMA. 2006;295:65-73.
15. Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ, et al. Predicting cirrosis risk based on the level of circulating hepatitis B viral Load. Gastroenterology. 2006;130:678-86.